글로벌 폰 빌레브란트병 치료 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 폰 빌레브란트병 치료 시장

폰 빌레브란트 질환 치료 시장은 2021년에서 2028년까지의 예측 기간 동안 6.75%의 시장 성장을 목격할 것으로 예상됩니다. 폰 빌레브란트 질환 치료 시장에 대한 Data Bridge Market Research 보고서는 예측 기간 내내 만연할 것으로 예상되는 다양한 요인에 대한 분석과 통찰력을 제공하고 시장 성장에 미치는 영향을 제공합니다. 전 세계적으로 유전적 질환의 유병률이 증가함에 따라 폰 빌레브란트 질환 치료 시장 성장이 가속화되고 있습니다.

폰 빌레브란트병(VWD)은 혈액 응고 과정을 지연시키는 유전적 질환을 말하며, 일반적으로 응고 단백질인 폰 빌레브란트 인자(VWF)가 없거나 결함이 있어서 발생합니다. 폰 빌레브란트 인자는 핵심 응고 단백질인 인자 VIII과 혈관 벽의 혈소판을 결합합니다.

The increase in the number of people suffering from Von Willebrand disease (VWD) across the globe acts as one of the major factors driving the growth of Von Willebrand disease treatment market. The initiatives by different organizations and governments to increase the efficacy and success rates of innovative treatments, and high need of drugs such as Antihemophilic Factor/Von Willebrand Factor Complex, Von Willebrand Factor/Coagulation Factor VIII Complex, and Von Willebrand factor (Recombinant), among others accelerate the market growth. The increase in in the number of acquisition strategies and company collaborations, and emerging new trends and recently approvals of drug further influence the market. Additionally, rise in prevalence of chronic diseases, developments in healthcare and high investment in healthcare sector positively affect the Von Willebrand disease treatment market. Furthermore, developments in novel treatments extend profitable opportunities to the market players in the forecast period of 2021 to 2028.

On the other hand, high cost associated with the treatment and diagnosis of Von Willebrand disease (VWD) is expected to obstruct the market growth. Lack of skilled expertise is projected to challenge the Von Willebrand disease treatment market in the forecast period of 2021-2028.

This Von Willebrand disease treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info Von Willebrand disease treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Global Von Willebrand Disease Treatment Market Scope and Market Size

The Von Willebrand disease treatment market is segmented on the basis of drugs, disease type, therapy type, mode of administration, distribution channel and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of drugs, the Von Willebrand disease treatment market is segmented into Antihemophilic Factor/Von Willebrand Factor Complex, Von Willebrand Factor/Coagulation Factor VIII Complex, Von Willebrand factor (Recombinant), and Desmopressin Acetate and Others.
• On the basis of disease type, the Von Willebrand disease treatment market is segmented into type 1 Von Willebrand disease, type 2 Von Willebrand disease, and type 3 Von Willebrand disease.
• On the basis of therapy type, the Von Willebrand disease treatment market is segmented into nonreplacement therapy and replacement therapy.
• On the basis of mode of administration, the Von Willebrand disease treatment market is segmented into injectable, oral and others.
• On the basis of distribution channel, the Von Willebrand disease treatment market is segmented into hospital pharmacies, retail pharmacies and online pharmacies.
• On the basis of end user, the Von Willebrand disease treatment market is segmented into hospitals, homecare, specialty clinics and others.

Von Willebrand Disease Treatment Market Country Level Analysis

The Von Willebrand disease treatment market is analyzed and market size information is provided by country, drugs, disease type, therapy type, mode of administration, distribution channel and end user as referenced above.

The countries covered in the Von Willebrand disease treatment market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America dominates the Von Willebrand disease treatment market due to the well-established health care infrastructure within the region. Asia-Pacific is expected to witness high growth during the forecast period of 2021 to 2028 because of the rise in health care infrastructure in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

폰 빌레브란트병 치료 시장은 또한 환자 분석, 예후 및 치료에 대한 자세한 시장 분석을 제공합니다. 유병률, 발생률, 사망률, 준수율은 보고서에서 사용할 수 있는 일부 데이터 변수입니다. 시장 성장에 대한 역학의 직접 또는 간접 영향 분석을 분석하여 성장 기간 동안 시장을 예측하기 위한 보다 견고하고 코호트 다변량 통계 모델을 만듭니다.

경쟁 환경 및 폰 빌레브란트병 치료 시장 점유율 분석

폰 빌레브란트병 치료 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 제공된 위의 데이터 포인트는 회사의 초점 관련 폰 빌레브란트병 치료 시장에만 관련이 있습니다.

폰 빌레브란트 질환 치료 시장 보고서에서 다루는 주요 기업으로는 Grifols, SA, Octapharma, CSL Limited, Ferring BV, Pfizer Inc., Kyowa Kirin Co., Ltd, Baxter, Novo Nordisk A/S, Bayer AG, Sanofi, China Biologic Products Holdings, Inc., Heritage, Teva Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals Ltd, Bausch Health, Amneal Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd, Mylan NV, Sagent Pharmaceuticals, Inc., Zydus Cadila 등이 있으며, 국내 및 글로벌 기업도 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA), 남미에 대해 각각 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-46587